Efficacy Long-term Dietary Nitrate Consumption to Plasma Nitrite Conversion

May 18, 2022 updated by: Gary Miller, Wake Forest University

Efficacy and Variability in Plasma Nitrite Levels During Long-term Supplementation With Nitrate Containing Beetroot Juice

The objective of this study was to determine the chronic effects of beetroot juice supplementation on the acute (90-minute post nitrate consumption) efficacy of converting dietary nitrate to plasma nitrate and plasma nitrite in healthy middle-to-older aged adults. the investigators were also interested in determining the effect of this intervention on fasting levels of plasma nitrate and nitrite over time. Furthermore, the number of participants classified as "non-responders" was determined based on increases in plasma nitrite achieved using tolerable volumes of beetroot juice by other studies.

Study Overview

Study Type

Interventional

Enrollment (Actual)

13

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Winston-Salem, North Carolina, United States, 27109
        • Wake Forest University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Middle and Older (40-80 year-old) men and women
  • Body mass index between 18.5 - 30.0 kg/m2
  • Able to provide own transportation to study testing visits
  • Able to consume study beverages
  • Able to speak and read English

Exclusion Criteria:

  • Tobacco user (smoke or chew), including e-cigarettes
  • Known conditions of: diabetes mellitus (type 1 or 2), atrophic gastritis, hypo- or hyperthyroidism, gout, history of kidney stones, history of hypotension, cardiovascular disease, chronic obstructive pulmonary disease, inflammatory bowel diseases, impaired liver or kidney function
  • Current or recent (last 3 months) treatment for cancer
  • Current use of the following medications: Phosphodiesterase type 5 inhibitors, nitroglycerin or nitrate preparations, proton pump inhibitors, medication for hypothyroidism, antacid and heartburn medications

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: BRJ Nitrate
This arm consumed daily for 12 weeks a 70 mL bottle of beetroot juice containing 380 mg of nitrate.
Participants in this group drank daily for 12 weeks a 70 mL bottle of Beet It Sport drink with nitrate.
Placebo Comparator: BRJ Placebo
This arm consumed daily for 12 weeks a 70 mL bottle of beetroot juice containing 0 mg of nitrate.
Participants in this group drank daily for 12 weeks a 70 mL bottle of Beet It Sport drink without nitrate

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fasting Plasma Nitrate
Time Frame: Collected at baseline (week 0), end of week 1, week 2, week 3, week 4, week 8, and week 12
Concentration of nitrate in the plasma obtained at the start of each testing visit
Collected at baseline (week 0), end of week 1, week 2, week 3, week 4, week 8, and week 12
Fasting Plasma Nitrite
Time Frame: Collected at baseline (week 0), end of week 1, week 2, week 3, week 4, week 8, and week 12
Concentration of nitrite in the plasma obtained at the start of each testing visit
Collected at baseline (week 0), end of week 1, week 2, week 3, week 4, week 8, and week 12
90 minute plasma Nitrate
Time Frame: Collected at baseline (week 0), end of week 1, week 2, week 3, week 4, week 8, and week 12
Concentration of nitrate in the plasma obtained 90 minutes following the consumption of the intervention arm's assigned beverage
Collected at baseline (week 0), end of week 1, week 2, week 3, week 4, week 8, and week 12
90 minute plasma Nitrite
Time Frame: Collected at baseline (week 0), end of week 1, week 2, week 3, week 4, week 8, and week 12
Concentration of nitrite in the plasma obtained 90 minutes following the consumption of the intervention arm's assigned beverage
Collected at baseline (week 0), end of week 1, week 2, week 3, week 4, week 8, and week 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2017

Primary Completion (Actual)

May 1, 2019

Study Completion (Actual)

May 1, 2019

Study Registration Dates

First Submitted

May 12, 2022

First Submitted That Met QC Criteria

May 12, 2022

First Posted (Actual)

May 18, 2022

Study Record Updates

Last Update Posted (Actual)

May 25, 2022

Last Update Submitted That Met QC Criteria

May 18, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRB000022922

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases in Old Age

Clinical Trials on BRJ Nitrate

3
Subscribe